Beneficial Effects of Dendrobium officinale Extract on Insomnia Rats Induced by Strong Light and Noise via Regulating GABA and GABAA Receptors.
10.1007/s11655-025-3925-7
- Author:
Heng-Pu ZHOU
1
;
Jie SU
1
;
Ke-Jian WEI
1
;
Su-Xiang WU
1
;
Jing-Jing YU
1
;
Yi-Kang YU
1
;
Zhuang-Wei NIU
1
;
Xiao-Hu JIN
1
;
Mei-Qiu YAN
1
;
Su-Hong CHEN
1
;
Gui-Yuan LYU
2
,
3
Author Information
1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
2. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China. zjtcmlgy@
3. com.
- Publication Type:Journal Article
- Keywords:
Dendrobium officinale;
Chinese medicine;
GABAA receptor;
gamma-aminobutyric acid;
insomnia;
sleep
- MeSH:
Animals;
Dendrobium/chemistry*;
Rats, Sprague-Dawley;
Male;
Sleep Initiation and Maintenance Disorders/blood*;
Plant Extracts/therapeutic use*;
Receptors, GABA-A/metabolism*;
Noise/adverse effects*;
Light/adverse effects*;
gamma-Aminobutyric Acid/metabolism*;
Sleep/drug effects*;
Rats;
Receptors, GABA/metabolism*
- From:
Chinese journal of integrative medicine
2025;31(6):490-498
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To explore the therapeutic effects and underlying mechanisms of Dendrobium officinale (Tiepi Shihu) extract (DOE) on insomnia.
METHODS:Forty-two male Sprague-Dawley rats were randomly divided into 6 groups (n=7 per group): normal control, model control, melatonin (MT, 40 mg/kg), and 3-dose DOE (0.25, 0.50, and 1.00 g/kg) groups. Rats were raised in a strong-light (10,000 LUX) and -noise (>80 db) environment (12 h/d) for 16 weeks to induce insomnia, and from week 10 to week 16, MT and DOE were correspondingly administered to rats. The behavior tests including sodium pentobarbital-induced sleep experiment, sucrose preference test, and autonomous activity test were used to evaluate changes in sleep and emotions of rats. The metabolic-related indicators such as blood pressure, blood viscosity, blood glucose, and uric acid in rats were measured. The pathological changes in the cornu ammonis 1 (CA1) region of rat brain were evaluated using hematoxylin and eosin staining and Nissl staining. Additionally, the sleep-related factors gamma-aminobutyric acid (GABA), glutamate (GA), 5-hydroxytryptamine (5-HT), and interleukin-6 (IL-6) were measured using enzyme linked immunosorbent assay. Finally, we screened potential sleep-improving receptors of DOE using polymerase chain reaction (PCR) array and validated the results with quantitative PCR and immunohistochemistry.
RESULTS:DOE significantly improved rats' sleep and mood, increased the sodium pentobarbital-induced sleep time and sucrose preference index, and reduced autonomic activity times (P<0.05 or P<0.01). DOE also had a good effect on metabolic abnormalities, significantly reducing triglyceride, blood glucose, blood pressure, and blood viscosity indicators (P<0.05 or P<0.01). DOE significantly increased the GABA content in hippocampus and reduced the GA/GABA ratio and IL-6 level (P<0.05 or P<0.01). In addition, DOE improved the pathological changes such as the disorder of cell arrangement in the hippocampus and the decrease of Nissel bodies. Seven differential genes were screened by PCR array, and the GABAA receptors (Gabra5, Gabra6, Gabrq) were selected for verification. The results showed that DOE could up-regulate their expressions (P<0.05 or P<0.01).
CONCLUSION:DOE demonstrated remarkable potential for improving insomnia, which may be through regulating GABAA receptors expressions and GA/GABA ratio.
